Serum neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury in asphyxiated neonates

Indian Pediatrics

Volumn 50, Issue 5, 2013, Pages 459-462

  El Raggal, N M ^a   Khafagy, Soha Mohamed ^a   Mahmoud, N H ^a   El Beltagy, S A ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Acute kidney injury; Asphyxia; Outcome

Indexed keywords

BIOLOGICAL MARKER; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ACUTE KIDNEY FAILURE; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; MALE; NEWBORN; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RELIABILITY; SENSITIVITY AND SPECIFICITY; UPREGULATION; BLOOD; NEWBORN HYPOXIA; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; ASPHYXIA NEONATORUM; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; LIPOCALINS; MALE; PROTO-ONCOGENE PROTEINS; TREATMENT OUTCOME;

EID: 84879005059     PISSN: 00196061     EISSN: 09747559     Source Type: Journal    
DOI: 10.1007/s13312-013-0153-6     Document Type: Article

References (17)

1. Andreoli SP. Acute renal failure in the newborn. Semin Perinatol. 2004;28:112-123.
2. Durkan AM, Alexander RT. Acute kidney injury post neonatal asphyxia. J Pediatr. 2011;158:e29-e33.
3. Gupta BD, Sharma P, Bagla JY, Parakh M, Soni J. Renal failure in asphyxiated neonates. Indian Pediatr. 2005;42:928-934.
4. Karlowicz MG, Adelman RD. Nonoliguric and oliguric acute renal failure in asphyxiated term neonates. Pediatr Nephrol. 1995;9:718-722.
5. Askenazi DJ, Ambalavanan NS, Goldstein SL. Acute kidney injury in critically ill newborns: What do we know? What do we need to learn? Pediatric Nephrol 2009; 24:265-274.
6. Krawczeski CD, Woo JG, Wang Y, Michael R, Ma Q, Deverajan P. Neutrophil gelatinase-associated Lipocalin concentrations predict development of acute kidney injury in neonates and children after cardiopulmonary bypass. J Pediatr. 2011;158;1009-1015.
7. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, et al. NGAL as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005; 365:1231-1238.
8. Use and Abuse of the Apgar score. Committee on fetus and Newborn, American Academy of Pediatrics and Committee on Obstetrics Practice, American College of Obstetrics and Gynecologists. Pediatrics. 1996;98:141-142.
9. Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-walsman BL, Lipp R. New Ballard score: expanded to include extremely premature infants. J Pediatr. 1991; 119:417-423.
10. Gharehbaghi MM, Peirovifar A. Evaluating causes of acute renal failure in newborn infants. Pak J Med Sci. 2007;23:877-880.
11. Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol. 1976;33:696-705.
12. Soni SS, Cruz D, Bobek I, Chionh CY, Nalesso F, Lentini P, et al. NGAL: A biomarker of acute kidney injury and other systemic conditions. Int Urol Nephrol. 2010;42:141-150.
13. Sarafidis K, Tsepkentzi E, Agakidou E, Diamanti E, Taparkou A, Soubasi V, et al. Serum and urine acute kidney injury biomarkers in asphyxiated neonates. Pediatr Nephrol. 2012; 27:1575-1582.
14. Drukker A, Guignard JP. Renal aspects of the term and preterm infant: a selective update. Curr Opin Pediatr. 2002;14:175-182.
15. Leake RD, Trygstad CW. Glomerular filtration rate during the period of adaptation to extrauterine life. Pediatr Res. 1977;11:959-962.
16. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Pawlak K, Mysliwiec M, et al. Neutrophil-Gelatinase-Associated Lipocalin (NGAL) correlations with Cystatin C, Serum creatinine and e GFR in patients with normal serum creatinine undergoing coronary angiography. Nephrology Dialysis transplantation. 2007; 22:295-296.
17. Koura HM, Galal A, Kandil DM, Elshamaa MF, Elghorori EA, Khalifa ES. Urinary Neutrophil Gelatinase-Associated Lipocalin as a marker of disease activity in patients with lupus nephritis. Int J Acad Res. 2011;3.